Search




Results 1-10 of 12.
 |   | 
JRC N°Publication YearTitleAuthor(s), Editor(s), Other Contributor(s)
JRC970482016Radioimmunothérapie alpha Principes et intérêts en immunité antitumoraleMENAGER J; GORIN J; FICHOU Nolwenn; GOUARD S.; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DAVODEAU F; KRAEBER BODÉRÉ F; CHEREL M.; GASCHET J; GUILLOUX Yannick
JRC901992016Long-Term Toxicity of 213Bi-Labelled BSA in MiceDORSO Laetitia; BIGOT-CORBEL Edith; ABADIE Jerome; DIAB Maya; GOUARD S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; MAUREL C; CHEREL M.; DAVODEAU F
JRC981452015Therapeutic efficacy of alpha-riT Using a 213Bi-anti-hcD138 antibody in a Mouse Model of Ovarian Peritoneal carcinomatosisDERRIEN Aurelie; GOUARD S.; MAUREL C; GAUGLER Marie-Helene; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FAIVRE-CHAUVET A; CLASSE Jean-Marc; CHEREL M.
JRC970472015Alpha particles induce autophagy in mutiple myeloma cellsGORIN J; GOUARD S.; MENAGER J; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; FAIVRE-CHAUVET A; GUILLOUX Yannick; CHEREL M.; DAVODEAU F; GASCHET J
JRC911652015Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor DestructionMENAGER J; GORIN J; MAUREL C; DRUJONT Lucile; GOUARD S.; LOUVET Cedric; CHEREL M.; FAIVRE-CHAUVET A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; DAVODEAU F; GASCHET J; GUILLOUX Yannick
JRC969652015Single-dose anti-CD138 radioimmunotherapy: bismuth-213 is more efficient than lutetium-177 for treatment of multiple myeloma in a preclinical modelFICHOU Nolwenn; GOUARD S.; MAUREL C; BARBET J; FERRER Ludovic; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; FAIVRE-CHAUVET A; BIGOT-CORBEL Edith; DAVODEAU F; GASCHET J; CHEREL M.
JRC848932014Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy.GOUARD S.; PALLARDY A; GASCHET J; FAIVRE-CHAUVET A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; MAUREL C; MATOUS E; KRAEBER BODÉRÉ F; DAVODEAU F; CHEREL M.
JRC855252014Anti-tumour immunity induced after alpha irradiationGORIN J; MENAGER J; GOUARD S.; MAUREL C; GUILLOUX Yannick; FAIVRE-CHAUVET A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; CHEREL M.; DAVODEAU F; GASCHET J
JRC655352013213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple MyelomaCHEREL M.; GOUARD S.; GASCHET J; SAÏ-MAUREL C; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; BOURGEOIS N.; GESTIN J.-f.; KRAEBER BODÉRÉ F; BARBET J; Moreau P; DAVODEAU F.
JRC827942013Comparative analysis of alpha radioimmunotherapy with bismuth-213-labeled anti-CD138 antibody and Melphalan chemotherapy for the treatment of multiple myeloma.GOUARD S.; PALLARDY A; GASCHET J; FAIVRE-CHAUVET A; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; MAUREL C; KRAEBER BODÉRÉ F; BARBET J; DAVODEAU F; CHEREL M.